Central histaminergic involvement during stress in rats.
Effects of some drugs modulating central histaminergic (HA) transmission were evaluated on restraint stress (RS)-induced gastric ulcerogenesis, plasma corticosterone and immune responses in rats. RS for (i) 6 hr or (ii) 24 hr at room temperature, and (iii) 3 hr at 4 degrees C (CRS) all induced gastric mucosal erosions and elevated plasma corticosterone levels, the effects with the latter two RS procedures being most consistent. Pretreatment of rats with neuronal HA depletor, alpha-FMH (100 mg/kg, ip) attenuated both ulcer severity and corticosterone response, during both 24 hr RS and CRS. Similar effects were also seen with the mast cell degranulator, C-48/80 (10 micrograms/kg, i.c.v.) treatment. Further, the H1-blocker, pheniramine (25 mg/kg, ip) but not the centrally acting H2-blocker, zolantidine (5 mg/kg, ip) produced clearcut attenuations in both stress markers, during the experimental stressors. In rats immunized in SRBC, 24 hr RS (and not CRS) significantly prevented the humoral immune responses to the antigen. alpha-FMH, C 48/80 and pheniramine but not zolantidine, reversed this response during 24 hr RS. The results indicate a central HA ergic involvement in the visceral, endocrinal and immune responses during RS and suggest the probable role of both neuronal as well as extraneuronal (mast cell) HA and activation of H1-receptors in the mediation of these effects.
Ray
A
A
Department of Pharmacology, University College of Medical Sciences, Delhi, India.
Puri
S
S
Chakravarty
A K
AK
Sen
P
P
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D052160:Benzothiazoles; D001921:Brain / Q000378:metabolism*; D003345:Corticosterone / Q000097:blood; D006632:Histamine / Q000502:physiology*; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors; D008297:Male; D008762:Methylhistidines / Q000494:pharmacology; D010437:Peptic Ulcer / Q000209:etiology; D010632:Pheniramine / Q000494:pharmacology; D050198:Phenoxypropanolamines; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013312:Stress, Physiological / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D013844:Thiazoles / Q000494:pharmacology
D052160:Benzothiazoles; D006635:Histamine H2 Antagonists; D008762:Methylhistidines; D050198:Phenoxypropanolamines; D010880:Piperidines; D013844:Thiazoles; D010632:Pheniramine; C028309:alpha-fluoromethylhistidine; D006632:Histamine; D006640:Histidine Decarboxylase; C055302:zolantidine; D003345:Corticosterone